Diagnostics Service

PLL THERAPEUTICS

The PLL Therapeutics approach: an overview

Our aims is to answer all the aspects of the medical needs …
Our approach aims to answer the main medical needs to treat ALS. It cover the following steps :

  • Early diagnostic : goal is to start the treatment as soon as possible
  • Treatment dosage : goal is to determine the best treatment dosage
  • Treatment follow-up : goal is to follow-up the patient with the diagnostic test and follow the evolution of the disease
Disease evolution
  • 1 | EARLY DIAGNOSTIC

  • – Early diagnostic kit with seric antibodies

    – Based on specific antibodies always present in ALS patients blood serum

  • 2 | TREATMENT Initiated

  • – Based on the specific antibodies, selection of the most adapted composition

    – Dose selection

  • 3 | TREATMENT Follow-up

  • – Adaptation of treatment dose thanks to companion diagnostic

    – Better response and increase life expectancy

    – Patient follow-up every 3-6 months

The PLL Therapeutics approach: diagnostics

Development of an accurate diagnostic solution to detect and follow the disease

  • Dedicated Kit (ALS)

    Confirmation of ALS diagnosis + patient follow-up

    SPECIFICS MARKERS LINK TO ALS DISEASE METABOLISM AND DYSBIOSIS

Indirect Elisa